AstraZeneca offers no comment after report saying CEO staying

Business

[ad_1]

LONDON (Reuters) – Anglo-Swedish pharmaceutical firm AstraZeneca (AZN.L) declined to comment on speculation about the future of its chief executive Pascal Soriot on Friday, after a report quoted Bloomberg news agency saying he would stay in his post.

The StreetInsider.com, citing Bloomberg, said Soriot was currently planning to stay for the foreseeable future.

When asked about the report, an AstraZeneca spokeswoman declined to comment, saying the firm had a policy of not responding to market speculation or rumors.

AstraZeneca has repeatedly declined to comment on Wednesday’s Israeli media report saying Soriot was in talks to join Israel’s Teva Pharmaceutical Industries (TEVA.TA). Uncertainty over his future has hit AstraZeneca’s shares.

Reporting by Paul Sandle; Editing by Edmund Blair

[ad_2]

Source link

Articles You May Like

Negli USA eseguito il primo trapianto di rene di maiale in un paziente in vita
Onu, cessate il fuoco a Gaza: è la prima volta
Assange può ricorrere contro l’estradizione negli Usa: la vittoria di una battaglia, non della guerra
Attentato di Mosca: Fsb accusa Ucraina, Usa e Gb, Kiev nega
Sassari: 27esimo suicidio in carcere dall’inizio dell’anno. Il SAPPE denuncia la situazione e chiede riforme urgenti

Leave a Reply

Your email address will not be published. Required fields are marked *